BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 18082413)

  • 41. Antiphospholipid antibodies and thrombosis: do test patterns identify the patients' risk?
    Galli M
    Thromb Res; 2004; 114(5-6):597-601. PubMed ID: 15507297
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Primary antiphospholipid antibody syndrome and cardiac involvement in a child.
    Clauss SB; Manco-Johnson MJ; Quivers E; Takemoto C; Spevak PJ
    Pediatr Cardiol; 2003; 24(3):292-4. PubMed ID: 12632226
    [TBL] [Abstract][Full Text] [Related]  

  • 43. New targeted therapies for treatment of thrombosis in antiphospholipid syndrome.
    Pierangeli SS; Vega-Ostertag ME; González EB
    Expert Rev Mol Med; 2007 Nov; 9(30):1-15. PubMed ID: 17997880
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The association of serum antiphospholipid antibodies and dilute Russell's viper venom times.
    Froom P; Saffuri-Elias E; Rozenberg O; Barak M
    J Clin Pathol; 2014 May; 67(5):441-4. PubMed ID: 24327661
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Experts consensus on clinical application of antiphospholipid antibodies detection].
    ; ;
    Zhonghua Nei Ke Za Zhi; 2019 Jul; 58(7):496-500. PubMed ID: 31269565
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment.
    Asherson RA; Cervera R; Merrill JT; Erkan D
    Semin Thromb Hemost; 2008 Apr; 34(3):256-66. PubMed ID: 18720305
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Primary antiphospholipid syndrome].
    Popa A; Voinea L; Pop M; Stana D; Dascalu AM; Alexandrescu C; Ciuluvica R
    Oftalmologia; 2008; 52(1):13-7. PubMed ID: 18714484
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiphosphatidylethanolamine antibodies and the antiphospholipid syndrome.
    Sanmarco M; Boffa MC
    Lupus; 2009 Sep; 18(10):920-3. PubMed ID: 19671793
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lupus anticoagulants: pathogenesis and laboratory diagnosis.
    Court EL
    Br J Biomed Sci; 1997 Dec; 54(4):287-98. PubMed ID: 9624740
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Antiphospholipid antibodies with HCV infection. Innocent proteins or risk factor?].
    Kisiel E; Kryczka W
    Przegl Lek; 2007; 64(7-8):521-4. PubMed ID: 18409357
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Primary, secondary, and catastrophic antiphospholipid syndrome: what's in a name?
    Harris EN; Pierangeli SS
    Semin Thromb Hemost; 2008 Apr; 34(3):219-26. PubMed ID: 18720301
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical utility of laboratory tests used to identify antiphospholipid antibodies and to diagnose the antiphospholipid syndrome.
    Galli M
    Semin Thromb Hemost; 2008 Jun; 34(4):329-34. PubMed ID: 18814065
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The risk of thrombosis in patients with lupus anticoagulants is predicted by their specific coagulation profile.
    Galli M; Finazzi G; Norbis F; Marziali S; Marchioli R; Barbui T
    Thromb Haemost; 1999 May; 81(5):695-700. PubMed ID: 10365739
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The significance of antiphospholipid antibodies].
    Fojtík Z
    Vnitr Lek; 2004 Apr; 50(4):312-7. PubMed ID: 15214303
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Laboratory diagnosis of the antiphospholipid syndrome: a plethora of obstacles to overcome.
    Devreese K; Hoylaerts MF
    Eur J Haematol; 2009 Jul; 83(1):1-16. PubMed ID: 19226362
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical laboratory testing for the antiphospholipid syndrome.
    Pierangeli SS; Harris EN
    Clin Chim Acta; 2005 Jul; 357(1):17-33. PubMed ID: 15893301
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Urgent termination of pregnancy in pre-eclampsia and panel of antiphospholipid antibodies.
    Hradecky L; Subrt I; Ulcova-Gallova Z
    Am J Reprod Immunol; 2009 Dec; 62(6):412-7. PubMed ID: 19895376
    [TBL] [Abstract][Full Text] [Related]  

  • 58. From antibody to clinical phenotype, the black box of the antiphospholipid syndrome: pathogenic mechanisms of the antiphospholipid syndrome.
    Du VX; Kelchtermans H; de Groot PG; de Laat B
    Thromb Res; 2013 Sep; 132(3):319-26. PubMed ID: 23958468
    [TBL] [Abstract][Full Text] [Related]  

  • 59. How to manage patients with systemic lupus erythematosus who are also antiphospholipid antibody positive.
    Giles I; Rahman A
    Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):525-37. PubMed ID: 19591782
    [TBL] [Abstract][Full Text] [Related]  

  • 60. European attempts for the standardisation of the antiphospholipid antibodies.
    Tincani A; Filippini M; Scarsi M; Galli M; Meroni PL
    Lupus; 2009 Sep; 18(10):913-9. PubMed ID: 19671792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.